- ►diabetesjournals.org B Guo, D Koya, M Isono, T Sugimoto, A … - Diabetes, 2004 - Am Diabetes Assoc The thiazolidinedione (TZD) class of antidiabetic drugs, which are ligands for
peroxisome proliferator-activated receptor (PPAR)- , has been shown to possess
potent anti-inflammatory and antineoplastic actions. Here, we show in ... Cited by 84 - Related articles - BL Direct - All 6 versions
B Guo, D Koya, M Isono, T Sugimoto, A … - Diabetes, 2004 - Am Diabetes Assoc The thiazolidinedione (TZD) class of antidiabetic drugs, which are ligands for
peroxisome proliferator–activated receptor (PPAR)- , has been shown to possess
potent anti-inflammatory and antineoplastic actions. Here, we show in ... Cited by 11 - Related articles
RS Chana, AJ Lewington, NJ Brunskill - Kidney international, 2004 - nature.com Peroxisome proliferator activated receptors (PPARs) are ligand-activated
transcription factors with multiple effects on target cell function. PPAR
activity is regulated by extracellular signal-regulated protein kinase ... Cited by 32 - Related articles - All 7 versions
- ►asnjournals.org S Zafiriou, SR Stanners, S Saad, TS Polhill, P … - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol Peroxisome proliferator–activated receptor- (PPAR- ) agonists are increasingly
used in patients with diabetes, and small studies have suggested a beneficial
effect on renal function, but their effects on extracellular matrix (ECM) ... Cited by 75 - Related articles - All 6 versions
A Gumieniczek - Life sciences, 2003 - Elsevier Impaired homeostasis under diabetic conditions is connected with the increased
production of free radicals and deficiency of antioxidative systems. The aim of
this study was to analyze the effect of new oral antidiabetic ... Cited by 27 - Related articles - All 5 versions
- ►physiology.org [PDF] F Zheng, A Fornoni, SJ Elliot, Y Guan, MD … - American Journal of Physiology- Renal Physiology, 2002 - Am Physiological Soc 10 other HighWire hosted articles, the first 5 are: This article has been cited
by ... [PDF] [Full Text] [Abstract] , April 1, 2007; 292 (4): C1361-C1369. Am J
Physiol Cell Physiol R. Mishra, L. Zhu, RL Eckert and MS Simonson TGF-beta- ... Cited by 84 - Related articles - BL Direct - All 4 versions
S Zafiriou, SR Stanners, TS Polhill, P … - Kidney international, 2004 - nature.com Pioglitazone caused a dose-dependent increase in tubular cell albumin uptake (P
< 0.0001). Despite the increase in albumin reabsorption, no concurrent increase
in inflammatory or profibrotic markers were observed. Exposure to LDL ... Cited by 52 - Related articles - BL Direct - All 5 versions
RE Routh, JH Johnson, KJ McCarthy - Kidney international, 2002 - nature.com Rat mesangial cells were grown in medium containing 5 mmol/L glucose, 30 mmol/L
glucose, or 5 mmol/L glucose plus 25 mmol/L mannitol. The cultures were either
left untreated, treated with 10 mol/L troglitazone (PPAR- ), or 100 mol/L ... Cited by 58 - Related articles - BL Direct - All 4 versions
A Maeda, S Horikoshi, T Gohda, T Tsuge, K … - Cell Biology International, 2005 - Elsevier The peroxisome proliferator-activated receptor (PPAR)γ is expressed not only in
adipose tissue but also in macrophages/monocytes and plays important roles in
acute/chronic inflammation. Transforming growth factor (TGF)-β is a common ... Cited by 33 - Related articles - All 3 versions
M Fu, J Zhang, X Zhu, DE Myles, TM Willson, … - Journal of Biological Chemistry, 2001 - ASBMB Activation of peroxisome proliferator-activated receptor γ (PPARγ) after
balloon injury significantly inhibits VSMC proliferation and neointima
formation. However, the precise mechanisms of this inhibition have not been ... Cited by 116 - Related articles - BL Direct - All 3 versions
